Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report Emilio Campos,1 Piera Versura,1 Giuseppe Giannaccare,1 Adriana Terzi,2 Silvia Bisti,3 Stefano Di Marco,3 and Marina Buzzi2 Show more Academic Editor: Nicola Rosa Received18 Apr 2018 Accepted14 Jun 2018 Published25 Jul 2018 Abstract Purpose. To report data which happened to be observed in two glaucoma patients treated with Cord Blood Serum […]
Cord Blood Serum
2020 will prove to be an excellent year for innovations in dry eye care and all health therapies. Recently multiple papers have come out & one recently by Dr. Pfugfelder and some colleagues from Harvard, Dr. Perez, Dr. Hamrah, Dr. Foster, Dr. Afshari, Dr. Dana, and my old mentor at NY Eye & Ear, Dr.
The Use of Cord Blood Serum (CBS) in Treating Multiple Conditions, Including Dry Eye Disease and Neuropathy/Neuropathic Eye Pain
Cord Blood Serum (CBS), also reported as Cord blood (CB) or Umbilical Cord Blood (UCB), has been used for the last 10 years as an accepted source of hematopoietic stem cells for the treatment of malignant and non-malignant hematological and immunological diseases (Ref 1-3). Cord Blood Serum is thus a life-saving treatment option for certain cancer patients that has
Patients with ocular pain or ocular discomfort, with a symptoms ranging from mild irritation, foreign body sensation to severe pain, often have an underlying meibomian gland, goblet cell, or lacrimal gland abnormality, which leads to a component of dry eye. Since the corneal nerves are so sensitive to changes in their microenvironment, even minor changes
Researchers in Italy reported two patients with glaucoma who used Cord Blood Serum and improved their Mean Deviation and Pattern Standard Deviation scores on visual fields, which is a key way to determine progression of glaucoma. This would be amazing if true. The key confounders are: 1. super small sample size of 2, and 2. Cord
We have now had two patients who have used Cord Blood Serum. Both patients have noted a dramatic improvement in symptoms. One patient went from a 9 out of 10 chronic pain to a 0 out of 10 pain. The other patient noted immediate relief and is now at a 2/10 pain from a 8/10
Exciting newly released study in the Journal of Ophthalmology, one of the top 3 journals in eye surgery: A group from Italy showed positive results in using Nerve Growth Factor (NGF) in patients with neurotrophic keratopathy or corneal neuropathy. NK is thought to occur from trigeminal nerve damage 9ie, trigeminal neuralgia[TGN]) and loss of corneal
Cord Blood Serum (CBS) and Autologous Serum (AS) There continue to be new studies on Cord Blood Serum and Autologous Serum for severe dry eye patients. In this 2015 study in the British Journal of Ophthalmology, patients with Leprosy affecting the eyes and causing severe dry eyes were evaluated showing Cord Blood Serums beneficial effect.